All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
INOZYME PHARMA, INC. Last Reported: 4/30/2024 Stock Symbol: INZY

Business Address

321 SUMMER STREET
SUITE 400
BOSTON , MA US 02210

Mailing Address

321 SUMMER STREET
SUITE 400
BOSTON , MA US 02210
Phone Number: 857-330-4340 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 7/31/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Cash and Cash Equivalents $20,618,000.00 $34,588,000.00 $46,895,000.00 $40,845,000.00 $32,915,000.00 $44,044,000.00 $62,620,000.00 $31,943,000.00 $23,316,000.00 $27,229,000.00 $26,239,000.00 $28,040,000.00 $59,858,000.00 -- $50,863,000.00 -- $31,605,000.00 $42,716,000.00 $45,136,000.00 -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $8,171,000.00 $7,661,000.00 $8,414,000.00 $3,341,000.00 $3,527,000.00 $4,474,000.00 $2,268,000.00 $2,810,000.00 $3,541,000.00 $5,296,000.00 $3,498,000.00 $3,282,000.00 $4,475,000.00 -- $793,000.00 -- $328,000.00 -- -- -- --
Total Current Assets $174,324,000.00 $196,250,000.00 $200,856,000.00 $143,588,000.00 $131,393,000.00 $145,926,000.00 $153,748,000.00 $100,583,000.00 $115,342,000.00 $130,579,000.00 $140,962,000.00 $150,979,000.00 $163,977,000.00 -- $64,660,000.00 -- $47,460,000.00 -- -- -- --
Property Plant and Equipement $1,316,000.00 $1,466,000.00 $1,584,000.00 $1,788,000.00 $2,018,000.00 $2,197,000.00 $2,208,000.00 $2,234,000.00 $2,383,000.00 $2,591,000.00 $2,611,000.00 $2,648,000.00 $2,455,000.00 -- $846,000.00 -- $298,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- $354,000.00 $354,000.00 $379,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Assets $176,943,000.00 $200,847,000.00 $205,702,000.00 $150,929,000.00 $139,195,000.00 $154,021,000.00 $161,989,000.00 $108,931,000.00 $123,541,000.00 $137,746,000.00 $148,259,000.00 $169,363,000.00 $178,993,000.00 -- $68,511,000.00 -- $47,944,000.00 -- -- -- --
Accounts Payable $2,166,000.00 $1,166,000.00 $2,006,000.00 $2,014,000.00 $2,544,000.00 $1,391,000.00 $1,339,000.00 $2,200,000.00 $2,394,000.00 $626,000.00 $796,000.00 $3,069,000.00 $3,665,000.00 -- $1,399,000.00 -- $901,000.00 -- -- -- --
Accrued Liabilities $9,306,000.00 $12,610,000.00 $9,383,000.00 $9,205,000.00 $11,355,000.00 $10,948,000.00 $8,461,000.00 $9,308,000.00 $8,508,000.00 $7,606,000.00 $5,485,000.00 $6,904,000.00 $6,149,000.00 -- $5,328,000.00 -- $2,335,000.00 -- -- -- --
Total Current Liabilities $58,107,000.00 $60,368,000.00 $45,489,000.00 $45,336,000.00 $20,801,000.00 $19,241,000.00 $12,813,000.00 $14,702,000.00 $14,273,000.00 $11,772,000.00 $9,985,000.00 $11,260,000.00 $11,077,000.00 -- $6,965,000.00 -- $3,236,000.00 -- -- -- --
Long Term Debt $45,032,000.00 $44,769,000.00 $32,065,000.00 $31,877,000.00 $4,139,000.00 $4,073,000.00 -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $428,212,000.00 $426,362,000.00 $424,671,000.00 $353,285,000.00 $333,356,000.00 $331,470,000.00 $329,414,000.00 $258,940,000.00 $256,948,000.00 $254,915,000.00 $252,920,000.00 $249,175,000.00 $247,872,000.00 -- $1,831,000.00 -- $1,428,000.00 -- -- -- --
Accumulated Other Comprehensive Loss $-105,000.00 $41,000.00 $-78,000.00 $51,000.00 $-205,000.00 $-477,000.00 $-397,000.00 $-129,000.00 $18,000.00 $3,000.00 $18,000.00 $2,000.00 -- -- $13,000.00 -- $5,000.00 -- -- -- --
Accumulated Deficit $-309,300,000.00 $-285,900,000.00 $-264,400,000.00 $-247,748,000.00 $-214,800,000.00 $-196,217,000.00 $-179,845,000.00 $-164,584,000.00 $-147,700,000.00 $-128,900,000.00 $-114,700,000.00 $-91,076,000.00 $-79,958,000.00 -- $-51,863,000.00 -- $-34,652,000.00 -- -- -- --
Total Stockholders' Equity $118,836,000.00 $140,479,000.00 $160,213,000.00 $105,593,000.00 $118,394,000.00 $134,780,000.00 $149,176,000.00 $94,229,000.00 $109,268,000.00 $125,974,000.00 $138,274,000.00 $158,103,000.00 $167,916,000.00 -- $-50,019,000.00 $-40,800,000.00 $-33,219,000.00 $-26,795,000.00 $-22,894,000.00 $-18,769,000.00 $-13,875,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $176,943,000.00 $200,847,000.00 $205,702,000.00 $150,929,000.00 $139,195,000.00 $154,021,000.00 $161,989,000.00 $108,931,000.00 $123,541,000.00 $137,746,000.00 $148,259,000.00 $169,363,000.00 $178,993,000.00 -- $68,511,000.00 -- $47,944,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021 9/30/2021 6/30/2021 12/31/2020 9/30/2020 7/31/2020 6/30/2020 3/31/2020 12/31/2019 9/30/2019 6/30/2019 3/31/2019 12/31/2018
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $19,111,000.00 $54,847,000.00 $13,341,000.00 $11,666,000.00 $47,849,000.00 $34,012,000.00 $21,821,000.00 $11,814,000.00 $37,720,000.00 $24,169,000.00 $14,823,000.00 $46,493,000.00 $39,457,000.00 -- $14,283,000.00 -- $16,220,000.00 $10,941,000.00 $3,489,000.00 -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $24,345,000.00 $75,645,000.00 $52,837,000.00 $16,394,000.00 $68,675,000.00 $16,912,000.00 $32,230,000.00 $16,839,000.00 $56,646,000.00 $14,262,000.00 $23,627,000.00 $57,041,000.00 $45,770,000.00 -- $9,548,000.00 -- $20,806,000.00 $14,038,000.00 $9,717,000.00 -- --
Loss from Operations $-24,345,000.00 $-75,645,000.00 $-52,837,000.00 $-34,763,000.00 $-68,675,000.00 $-49,142,000.00 $-32,230,000.00 $-16,839,000.00 $-56,646,000.00 $-37,889,000.00 $-23,627,000.00 $-57,041,000.00 $-45,770,000.00 -- $-17,454,000.00 -- $-20,806,000.00 $-14,038,000.00 $-9,717,000.00 -- --
Loss Before Income Taxes -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.38 $-1.37 $-1.02 $-0.35 $-1.78 $-1.36 $-0.38 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic 61,772,279 51,839,131 48,494,175 44,293,577 37,763,168 43,657,718 39,703,550 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted $-0.38 $-1.37 $-0.29 $-0.74 $-1.78 $-0.38 $-1.01 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted 61,772,279 51,839,131 48,494,175 44,293,577 37,763,168 43,657,718 39,703,550 -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 200,000,000 129,000,000 -- 129,000,000 -- -- -- --
Common Stock Shares Outstanding 61,816,509 61,768,771 61,760,748 46,379,088 40,394,363 40,394,363 40,097,076 23,818,411 23,668,747 23,664,747 23,570,593 23,384,969 23,364,851 -- 1,344,704 -- 1,204,630 -- -- -- --
Common Stock Value $6,000.00 $6,000.00 $6,000.00 $5,000.00 $4,000.00 $4,000.00 $4,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 $2,000.00 -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- $0.00 -- $0.00 -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -- -- -- $0.00 -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com